SeraCare, founded in 1984, is a leading partner to global In Vitro diagnostics manufacturers and clinical laboratories. Part of LGC since 2018, it manufactures and supplies quality control materials for infectious disease testing through its ACCURUN® reagents, as well as the Seraseq® range of products for the clinical next-generation sequencing market in the fields of oncology, NIPT, and inherited disease testing. A broad selection of highly multiplexed, patient-like reference materials with clinically-relevant DNA and RNA variants is available, manufactured in cGMP-compliant, ISO 13485-certified facilities.
SeraCare's flagship product cover:
ACCURUN® controls and reference materials: Designed to be weakly reactive to help monitor serology assays for additional confidence in laboratory test results.
Seraseq® Next-generation sequencing (NGS) reference materials: Helping scientists and clinicians build, validate, implement, and standardize better clinical genomics assays.
Customizable biological materials: Enabling leading diagnostic assay developers to build more robust assays, faster. SeraCare’s readily available antibodies and immunoassay reagents will accelerate research and IVD assay development.
Contact LGC Clinical Diagnostics
Whether releasing patient results with confidence or advancing cutting-edge research, you need a partner that is responsive, reliable and agile. Please get in touch and see how we can collaborate to change the future of clinical diagnostics.Get in Touch